Q1 FY27, unaudited
- Revenue
- ₹403.02 Cr
- Profit after tax
- ₹27.32 Cr
As filed with the exchange, standalone basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | FY26 |
|---|---|---|---|
| Revenue from operations | 403.02 | +19.87% | 1,302.97 |
| Other income | 5.77 | −9.28% | 46.76 |
| Total income | 408.79 | +19.33% | 1,349.73 |
| Employee benefit expense | 26.12 | +13.42% | 90.42 |
| Finance costs | 0.30 | −18.92% | 1.39 |
| Depreciation & amortisation | 13.40 | +0.45% | 53.54 |
| Total expenses | 372.31 | +16.22% | 1,261.00 |
| Profit before tax | 36.48 | +64.10% | 83.81 |
| Tax expense | 9.16 | +62.12% | 19.72 |
| Profit after tax | 27.32 | +64.78% | 64.09 |
| Total comprehensive income | 56.96 | +151.48% | 51.05 |
| Earnings per share, basic | ₹1.64 | ₹3.84 |
|---|---|---|
| Earnings per share, diluted | ₹1.63 | ₹3.83 |
Earnings call
Q1 FY27NOCIL reported Q1 FY27 revenue of Rs 403 crores, up 20% year-on-year and 22% sequentially, driven by 9% volume growth and higher selling prices linked to raw material costs. EBITDA rose 48% YoY to Rs 45 crores with margins at 11.2%, while PAT grew 61% YoY to Rs 28 crores. Management discussed anti-dumping duty developments on Sulphonamides and Pilflex 13, progress at the new TDQ plant in Dahej, and gave revenue and margin guidance for FY27.
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary
Filings
12 shown · 45 published by the exchange
25 Aug 2026
Filing10 Aug 2026
Transcript04 Aug 2026
04 Aug 2026
04 Aug 2026
Filing03 Aug 2026
03 Aug 2026
Filing03 Aug 2026
03 Aug 2026
Presentation03 Aug 2026
03 Aug 2026
01 Aug 2026
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Page generated from filings held to 25 Aug 2026.